Literature DB >> 3735460

Carcinogenic effects of antimony trioxide and antimony ore concentrate in rats.

D H Groth, L E Stettler, J R Burg, W M Busey, G C Grant, L Wong.   

Abstract

This study was initiated because of a suspected increase in incidence of lung cancer in antimony smelter workers in England. Three groups of 8-mo-old Wistar-derived rats (90 males and 90 females per group) were exposed by inhalation to either Sb2O3 [time-weighted average (TWA) 45 mg/m3], Sb ore concentrate (TWA 36 + 40 mg/m3), or filtered air (controls) for 7 h/d, 5 d/wk, for up to 52 wk and sacrificed 20 wk after terminating exposures. Serial sacrifices (5 rats/sex/group) were performed at 6, 9, and 12 mo. Autopsies and histopathological examinations were performed on all animals. The dusts and animal tissues were analyzed for Sb, arsenic, and other inorganic elements by atomic absorption and proton-induced X-ray emission methods. The most significant findings were the presence of lung neoplasms in 27% of females exposed to Sb2O3 and 25% of females exposed to Sb ore concentrate (p less than 0.01). None of the male rats in any group or the female controls developed lung neoplasms. There were no significant differences in incidences of cancer of other organs between exposed and control rats. These results were compared with other published results, including an animal inhalation study with Sb2O3 in which lung tumors were also induced. Higher concentrations of arsenic were found in tissues from female rats than from male rats. For example, arsenic levels in blood of control males, control females, Sb2O3 males, Sb2O3 females, Sb ore males, and Sb ore females were 60, 123, 115, 230, 71, and 165 micrograms arsenic/g dry blood, respectively, 9 mo after initiating exposures.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3735460     DOI: 10.1080/15287398609530898

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  12 in total

1.  Comparison of the clastogenic effects of antimony trioxide on mice in vivo following acute and chronic exposure.

Authors:  N Gurnani; A Sharma; G Talukder
Journal:  Biometals       Date:  1992       Impact factor: 2.949

2.  Survey of antimony workers: mortality 1961-1992.

Authors:  R D Jones
Journal:  Occup Environ Med       Date:  1994-11       Impact factor: 4.402

3.  External and internal antimony exposure in starter battery production.

Authors:  M Kentner; M Leinemann; K H Schaller; D Weltle; G Lehnert
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

Review 4.  Hazardous air pollutants and asthma.

Authors:  George D Leikauf
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

Review 5.  Relevance of particle-induced rat lung tumors for assessing lung carcinogenic hazard and human lung cancer risk.

Authors:  J L Mauderly
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

6.  Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure.

Authors:  T W Gebel; R H Suchenwirth; C Bolten; H H Dunkelberg
Journal:  Environ Health Perspect       Date:  1998-01       Impact factor: 9.031

Review 7.  Epidemiological and experimental aspects of metal carcinogenesis: physicochemical properties, kinetics, and the active species.

Authors:  L Magos
Journal:  Environ Health Perspect       Date:  1991-11       Impact factor: 9.031

8.  The industrial toxicology of antimony. The Ernestine Henry lecture 1987.

Authors:  R I McCallum
Journal:  J R Coll Physicians Lond       Date:  1989-01

9.  Risk of Cancer for Workers Exposed to Antimony Compounds: A Systematic Review.

Authors:  Anton Saerens; Manosij Ghosh; Jelle Verdonck; Lode Godderis
Journal:  Int J Environ Res Public Health       Date:  2019-11-14       Impact factor: 3.390

10.  Assessment of Industrial Antimony Exposure and Immunologic Function for Workers in Taiwan.

Authors:  Chin-Ching Wu; Yi-Chun Chen
Journal:  Int J Environ Res Public Health       Date:  2017-06-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.